Survival after introduction of HAART in people with known duration of HIV-1 infection
Survival after introduction of HAART in people with known duration of HIV-1 infection
复制标题
DOI：
10.1016/s0140-6736(00)02069-9
复制
发表时间：
2000-04-01
期刊：
影响因子：
168.9
通讯作者：
中科院分区：
文献类型：
--
作者：
我们比较了在高效抗逆转录病毒治疗（HAART）之前和期间HIV-1血清转换的存活率。与1986-96年（HAART前时期）相比，1997-98年（HAART时期）HIV-1感染者的生存预期明显更好。从血清转化10年的估计存活率在后期也明显更好。
We compared survival from HIV-1 seroconversion before and during the periods of highly-active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV-l-infected individuals in 1997-98 (HAART period) compared with those in 1986-96 (pre-HAART period). Estimated survival 10 years from seroconversion was also substantially better in the later period.